We have updated our Privacy Policy. Please review our Privacy Policy. This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our Privacy Policy.

Close
VIVITROL is a prescription injectable medicine used to:
  • Treat alcohol dependence. You should stop drinking before starting VIVITROL.
  • Prevent relapse to opioid dependence, after opioid detoxification.

You must stop taking opioids before you start receiving VIVITROL. To be effective, VIVITROL must be used with other alcohol or drug recovery programs such as counseling.

VIVITROL may not work for everyone. It is not known if VIVITROL is safe and effective in children.

ONCE-MONTHLY VIVITROL ALONG WITH COUNSELING MAY GIVE YOU A PATH FORWARD IN YOUR alcohol dependence RECOVERY JOURNEY1

Continually facing the consequences of alcohol dependence can be a challenge, but you are not alone.

VIVITROL and counseling may be able to help.

VIVITROL and counseling has been proven to reduce the number of heavy drinking days* in patients with alcohol dependence who are able to abstain in an outpatient setting1,2

In a study of 624 patients with alcohol dependence, those who received VIVITROL and counseling had 25% fewer heavy drinking days* per month compared with those who received placebo (injection without medication) and counseling. Patients were studied for 6 months in an outpatient setting.

*Heavy drinking days were defined as 5 or more drinks per day for men and 4 or more drinks per day for women.

A small group of patients in the same 6-month study did not drink alcohol for one week before the study began. Within this group, the patients who received VIVITROL were more likely to not drink any alcohol during the study compared with patients who received placebo1,2

There were 53 patients who had stopped drinking alcohol completely one week prior to their first injection. Among this group, 41% of patients who received VIVITROL did not drink any alcohol throughout the study compared with 17% of those who received placebo.

The same result was not seen in patients who were still drinking at the start of the study.

Common side effects of VIVITROL in clinical studies included nausea, sleepiness, headache, dizziness, vomiting, decreased appetite, painful joints, muscle cramps, cold symptoms, trouble sleeping, and toothache.

Please see Important Safety Information

VIVITROL is a once-monthly injection

Your recovery journey is worth fighting for.

ASK YOUR HEALTHCARE PROVIDER IF
ONCE-MONTHLY VIVITROL MAY BE RIGHT FOR YOU.


SETTING TREATMENT GOALS FOR YOUR RECOVERY JOURNEY

On the road to recovery, there may be challenges along the way. Revisiting treatment goals with your doctor may help you stay motivated in your recovery.3

start now

NEED HELP PREPARING FOR TREATMENT?

These tips may help you prepare for your VIVITROL injection.

Learn more

VIVITROL is not right for everyone. There are significant risks from VIVITROL treatment, including risk of opioid overdose, severe reactions at the injection site, sudden opioid withdrawal, liver damage or hepatitis.

Talk to your healthcare provider about naloxone, a medicine that is available to patients for the emergency treatment of an opioid overdose.

Call 911 or get emergency medical help right away in all cases of known or suspected opioid overdose, even if naloxone is administered.

If you are being treated for alcohol dependence but also use or are addicted to opioid-containing medicines or opioid street drugs, it is important that you tell your healthcare provider before starting VIVITROL to avoid having sudden opioid withdrawal symptoms when you start VIVITROL treatment.

See Important Safety Information.

See Prescribing Information and Medication Guide.


References: 1. VIVITROL [prescribing information]. Waltham, MA: Alkermes, Inc. 2. Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617-1625. 3. Substance Abuse and Mental Health Services Administration (SAMHSA). Enhancing motivation for change in substance use disorder treatment. Treatment Improvement Protocol (TIP) 35. SAMHSA Publication No. EP19-02-01-003. Printed 2019.

References: 1. VIVITROL [prescribing information]. Waltham, MA: Alkermes, Inc. 2. Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617-1625. 3. Substance Abuse and Mental Health Services Administration (SAMHSA). Enhancing motivation for change in substance use disorder treatment. Treatment Improvement Protocol (TIP) 35. SAMHSA Publication No. EP19-02-01-003. Printed 2019.

We have updated our Privacy Policy. Please review our Privacy Policy. This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our Privacy Policy.

Close